A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00216502
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : January 24, 2011
Information provided by:
Janssen-Cilag S.p.A.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : November 2005